Department of Medicine

August 4, 2022

Study shows success at disproving allergies to sulfa antibiotics

A Vanderbilt study shows that physicians can successfully identify and disprove low-risk sulfa antibiotic allergies using an oral antibiotic challenge in consenting patients prior to solid organ transplant.

By Nancy Humphrey
August 4, 2022

VUMC lauded for scleroderma treatment, research

Vanderbilt University Medical Center was recently listed as a Designated Scleroderma Research and Treatment Center by the National Scleroderma Foundation.

By Doug Campbell
August 3, 2022

Embryo screening for mental illness questioned

Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life.

By Bill Snyder
Pregnant woman holding pill pack
August 2, 2022

Targeted cancer drug during pregnancy

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

By Leigh MacMillan
Officials with Vanderbilt Wilson County Hospital cut the ribbon celebrating the relaunch of the hospital’s percutaneous coronary intervention program. (photo by Donn Jones)
August 1, 2022

VWCH relaunches interventional cardiology program

Vanderbilt Wilson County Hospital has launched a percutaneous coronary intervention program to treat patients diagnosed with heart attacks and coronary artery disease.

By Emily Stembridge
August 1, 2022

H. pylori and lung cancer

Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.

By Leigh MacMillan
July 28, 2022

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
By Bill Snyder
July 28, 2022

Department of Medicine announces August Grand Rounds

By VUMC News and Communications
July 28, 2022

Study reveals need for matching targeted therapies with EGFR subtypes

A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
By Tom Wilemon
July 21, 2022

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development
By Leah Mann
July 21, 2022

VIGH, VICC establish cancer research program in Zambia

Vanderbilt University Medical Center and the University of Zambia (UNZA) are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia.
By Kristin Centers
July 21, 2022

Longtime division leader earns degree, accolades

Vanderbilt's Amy Shelton, MS, has been awarded a Master of Science Degree in Research Administration with Honors from the Johns Hopkins University Krieger School of Arts and Sciences.
By Bill Snyder
July 20, 2022

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
By Leigh MacMillan
1 … 42 43 44 45 46 … 125